111 related articles for article (PubMed ID: 12719884)
21. Allogeneic stem cell transplant for chronic myeloid leukemia as a still promising option in the era of the new target therapy.
Stamatović D; Balint B; Tukić L; Elez M; Tarabar O; Todorović M; Todorić-Zivanović B; Ostojić G; Tatomirović Z; Marjanović S; Malesević M
Vojnosanit Pregl; 2012 Jan; 69(1):37-42. PubMed ID: 22397295
[TBL] [Abstract][Full Text] [Related]
22. Lymphoid blast crisis of chronic myelogenous leukemia occurring more than 11 years after receiving an allogeneic bone marrow transplant for chronic myelogenous leukemia in myeloid blast crisis at onset.
Fukuno K; Tsurumi H; Yamada T; Oyama M; Matsuyama T; Terakura S; Kodera Y; Moriwaki H
Bone Marrow Transplant; 2003 Feb; 31(3):211-3. PubMed ID: 12621483
[TBL] [Abstract][Full Text] [Related]
23. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
24. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
[TBL] [Abstract][Full Text] [Related]
25. Allogeneic stem cell transplantation for chronic myeloid leukemia.
Barrett J
Semin Hematol; 2003 Jan; 40(1):59-71. PubMed ID: 12563612
[TBL] [Abstract][Full Text] [Related]
26. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
[TBL] [Abstract][Full Text] [Related]
27. Pediatric secondary chronic myeloid leukemia following cardiac transplantation for anthracycline-induced cardiomyopathy.
Menon NM; Katsanis E; Khalpey Z; Whitlow P
Pediatr Blood Cancer; 2015 Jan; 62(1):166-8. PubMed ID: 25175922
[TBL] [Abstract][Full Text] [Related]
28. Molecular basis for therapeutic decisions in chronic myeloid leukemia patients after allogeneic bone marrow transplantation.
Román J; Alvarez MA; Torres A
Haematologica; 2000 Oct; 85(10):1072-82. PubMed ID: 11025600
[TBL] [Abstract][Full Text] [Related]
29. Extended follow-up of patients treated with imatinib mesylate (gleevec) for chronic myelogenous leukemia relapse after allogeneic transplantation: durable cytogenetic remission and conversion to complete donor chimerism without graft-versus-host disease.
DeAngelo DJ; Hochberg EP; Alyea EP; Longtine J; Lee S; Galinsky I; Parekkedon B; Ritz J; Antin JH; Stone RM; Soiffer RJ
Clin Cancer Res; 2004 Aug; 10(15):5065-71. PubMed ID: 15297408
[TBL] [Abstract][Full Text] [Related]
30. Long-term results after allogeneic bone marrow transplantation for chronic myelogenous leukemia in chronic phase: a report from the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
van Rhee F; Szydlo RM; Hermans J; Devergie A; Frassoni F; Arcese W; de Witte T; Kolb HJ; Niederwiser D; Jacobsen N; Gahrton G; Bandini G; Carreras E; Bacigalupo A; Michallet M; Ruutu T; Reiffers J; Goldman JM; Apperley J; Gratwohl A
Bone Marrow Transplant; 1997 Oct; 20(7):553-60. PubMed ID: 9337056
[TBL] [Abstract][Full Text] [Related]
31. [Synchronous tumors consisted of bronchial carcinoid and adenocarcinoma of the lung].
Yano K; Yokoi K; Matsuguma H; Anraku M; Kondo T; Kamiyama Y; Mori K; Igarashi S
Kyobu Geka; 2002 Jun; 55(6):457-60. PubMed ID: 12058455
[TBL] [Abstract][Full Text] [Related]
32. Successful allogeneic haematopoietic stem cell transplantation in patients with poor-risk leukaemia and prior invasive fungal infection.
Mehta P; Augustson B; Krishnamurthy S; Jacob A; Roy D; Olliff J; Cook M; Craddock C; Mahendra P
Bone Marrow Transplant; 2004 Nov; 34(9):825-6. PubMed ID: 15361904
[No Abstract] [Full Text] [Related]
33. Resolution of psoriasis following allogeneic bone marrow transplantation for chronic myelogenous leukemia: case report and review of the literature.
Kanamori H; Tanaka M; Kawaguchi H; Yamaji S; Fujimaki K; Tomita N; Fujisawa S; Ishigatsubo Y
Am J Hematol; 2002 Sep; 71(1):41-4. PubMed ID: 12221673
[TBL] [Abstract][Full Text] [Related]
34. Eradication of residual bcr-abl-positive clones by inducing graft-versus-host disease after allogeneic stem cell transplantation in patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Matsue K; Tabayashi T; Yamada K; Takeuchi M
Bone Marrow Transplant; 2002 Jan; 29(1):63-6. PubMed ID: 11840146
[TBL] [Abstract][Full Text] [Related]
35. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
Gaiger A; Lion T; Kalhs P; Mitterbauer G; Henn T; Haas O; Födinger M; Kier P; Forstinger C; Quehenberger P
Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
[TBL] [Abstract][Full Text] [Related]
36. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
[TBL] [Abstract][Full Text] [Related]
37. Essential thrombocythemia after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
Khoury H; Adkins D; Zehnbauer B; Goodnough L; Brown R; Safdar S; DiPersio JF
Bone Marrow Transplant; 1998 Jul; 22(1):107-9. PubMed ID: 9678805
[TBL] [Abstract][Full Text] [Related]
38. Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.
Weber T; Ocheni S; Binder M; Theurich S; Scheid C; Schmid C; Müller LP; Christopeit M; Bacher U
Acta Haematol; 2013; 129(3):135-6. PubMed ID: 23207834
[No Abstract] [Full Text] [Related]
39. Thiotepa, busulfan and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced chronic myelogenous leukemia.
Przepiorka D; Khouri I; Thall P; Mehra R; Lee MS; Ippoliti C; Giralt S; Gajewski J; van Besien K; Andersson B; Körbling M; Deisseroth AB; Champlin R
Bone Marrow Transplant; 1999 May; 23(10):977-81. PubMed ID: 10373061
[TBL] [Abstract][Full Text] [Related]
40. Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia.
Ruiz-Argüelles GJ; Gómez-Almaguer D; López-Martínez B; Cantú-Rodríguez OG; Jaime-Pérez JC; González-Llano O
Haematologica; 2002 Aug; 87(8):894-6. PubMed ID: 12161373
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
